IDX Stock Overview
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Integral Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.19 |
| 52 Week High | AU$3.18 |
| 52 Week Low | AU$1.92 |
| Beta | 0.69 |
| 1 Month Change | -26.63% |
| 3 Month Change | -27.72% |
| 1 Year Change | 1.86% |
| 3 Year Change | -42.06% |
| 5 Year Change | -7.98% |
| Change since IPO | 15.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| IDX | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -4.8% | -2.3% | -2.0% |
| 1Y | 1.9% | -17.9% | -0.4% |
Return vs Industry: IDX exceeded the Australian Healthcare industry which returned -17.9% over the past year.
Return vs Market: IDX exceeded the Australian Market which returned -0.4% over the past year.
Price Volatility
| IDX volatility | |
|---|---|
| IDX Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in AU Market | 15.7% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: IDX has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: IDX's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,977 | Ian Kadish | www.integraldiagnostics.com.au |
Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.
Integral Diagnostics Limited Fundamentals Summary
| IDX fundamental statistics | |
|---|---|
| Market cap | AU$817.53m |
| Earnings (TTM) | AU$5.66m |
| Revenue (TTM) | AU$491.32m |
144.4x
P/E Ratio1.7x
P/S RatioIs IDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDX income statement (TTM) | |
|---|---|
| Revenue | AU$491.32m |
| Cost of Revenue | AU$335.79m |
| Gross Profit | AU$155.53m |
| Other Expenses | AU$149.87m |
| Earnings | AU$5.66m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Aug 26, 2025
| Earnings per share (EPS) | 0.015 |
| Gross Margin | 31.66% |
| Net Profit Margin | 1.15% |
| Debt/Equity Ratio | 46.3% |
How did IDX perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield247%
Payout RatioDoes IDX pay a reliable dividends?
See IDX dividend history and benchmarks| Integral Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Mar 06 2025 |
| Dividend Pay Date | Apr 07 2025 |
| Days until Ex dividend | 10 days |
| Days until Dividend pay date | 22 days |
Does IDX pay a reliable dividends?
See IDX dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/15 11:41 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integral Diagnostics Limited is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Yeo | Barrenjoey Markets Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |